Nexgen to join WHO's R&D project for rabies antibody

Published: 2006-01-16 06:58:00

Updated: 2006-01-16 06:58:00

Nexgen, a plant genetic engineering venture company, announced on Jan. 10 about their participation in the WHO's project for the rabies antibody development by the use of plant as a part of "Pharma-Planta consortium" proceeded by EU.

The company said "Our molecular farming technology has been recognized by this occasion".

Nexgen succeeded in developing a technology for the production of ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.